RAPTOR PHARMACEUTICAL CORP's ticker is and the CUSIP is 75382F906. A total of 4 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $7,000 | -77.4% | 3,145 | +761.6% | 0.00% | -100.0% |
| Q2 2016 | $31,000 | – | 365 | +676.6% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 47 | -88.2% | 0.00% | – |
| Q4 2015 | $2,000 | -60.0% | 400 | +9.3% | 0.00% | – |
| Q3 2015 | $5,000 | -97.6% | 366 | -25.6% | 0.00% | -100.0% |
| Q2 2015 | $208,000 | +333.3% | 492 | +34.4% | 0.02% | +183.3% |
| Q1 2015 | $48,000 | +4700.0% | 366 | +18200.0% | 0.01% | – |
| Q4 2014 | $1,000 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 47,700 | $713,000 | 0.01% |
| Citadel Advisors | 16,800 | $251,000 | 0.00% |